Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas...
Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in...
A study published today in the journal Nature Medicine led by researchers at Huntsman Cancer Institute (HCI) at the Ï㽶ÊÓƵ of Utah (U of U) describes a new therapeutic approach...
HCI patient Clark Stringham felt like he was running out of time with his diagnosis of advanced prostate cancer. He credits a clinical trial and his oncologist, Neeraj Agarwal, MD...
The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can...
When construction is complete in 2021, Huntsman Cancer Institute will implement the latest advance in proton therapy, called intensity-modulated proton therapy. Proton therapy is the favored approach for many tumors...
In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that...
Ignacio Garrido-Laguna, MD, PhD, is a gastrointestinal oncologist with a special interest in pancreas cancer. In this interview, he tells us about his home and his medical training in Spain...
The American Society of Clinical Oncology recently published Clinical Cancer Advances, their 2019 annual report on the progress against cancer. The report examines the most transformative research of the past...
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Thomas Varghese Jr, MD, MS, was recently honored with a Huntsman Translational Scholar...
